Coconut Creek, Fla. – August 30, 2012– Greyson International, Inc. (GYSN.PK) announced today that it has received its issue date and Patent number from the U.S. Patent and Trademark Office.  The Patent will be issued on September 18, 2012 and the Patent Number is 8,268,335.

The Trilexon® Delivery System Technology, allows active ingredients to work for a longer period of time than other products currently available on the market, and therefore produces results never before possible. The Trilexon® delivery system can improve the effectiveness of virtually every topical application in almost any field imaginable.

Greyson International CEO, Harvey Tauman, said “We are very confident that this patent will support us in moving forward with marketing and licensing agreements wherever active ingredients are needed. This trans-dermal delivery system could be used more effectively in cosmetic, medical and veterinary use.”

The patent is classified as a “Utility” patent and, according to the US Patent Office; a utility patent is only obtained when the invention is for a “new and useful process, machine, manufacture, or composition of matter.”

About Greyson International, Inc.

Greyson International, Inc. is a research, development and marketing company that markets health and beauty aid products. Trilexon® is a registered trademark of Greyson International. For more information, visit www.greysonintl.com; join the Greyson Facebook group page by visiting www.facebook.com.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

 

† Trilexon® is a registered trademark of Greyson International, Inc.

 

Coconut Creek, Fla. – February 4, 2013 – Greyson International, Inc. (OTCPINK: GYSN), developer of an innovative, patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced that it has scheduled an investor conference call for February 20, 2013 at 4:15 pm EDT.  Greyson will provide updates on product development and entry into new product categories, the formation of our Bio-Medical subsidiary, an update on Greyson’s energy assets, as well as an update on all other aspects of Greyson’s business. Conference call specifics will be announced at a later date.

Greyson International CEO Harvey Tauman stated, “Our company has made tremendous progress over the last several months and I’m looking forward to outlining these accomplishments as well as discussing our future plans on this call.”

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system that’s taking the multi-billion dollar cosmetics and OTC pharmaceuticals industries by storm. Based on this technology, the company’s patented Trilexon® foundation creates a fine surface that is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time, ensuring that the skin receives treatment at a constant steady pace to give it a healthy and youthful look. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. The company also holds an investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered, Oil and Gas Company. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

COCONUT CREEK, Fla. – January 22, 2013- Greyson International Inc. (Pink Sheets: GYSN), developer of an innovative patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced that it engaged beauty and lifestyle futurologist Jeanine Recckio and the Mirror Mirror Imagination Group to bring its patented breakthrough Trilexon® technology and cosmetic products to the next level.

“We are very excited to have engaged Jeanine Recckio to help us effectively introduce both our existing and future product lines into the retail market,” said Harvey Tauman, CEO of Greyson International Inc. “With our patented revolutionary topical Trilexon® delivery technology and several cosmetic products already in place, we are excited to bring our breakthrough products to market and ultimately unlock significant shareholder value over the coming quarters.”

Formerly a top executive at global cosmetic giants like Revlon, Estee Lauder, Coty, L’Oreal, Helena Rubinstein and Ralph Lauren Fragrances, Ms. Recckio’s trend forecasting agency Mirror Mirror Imagination Group© focuses on identifying trends that drive new business, and lending its expertise in developing, packaging, positioning and selling Fortune 500 products into retail channels like Colgate-Palmolive, P&G, Sephora, QVC, Nivea, LaPrairie, Garnier and more to launch innovative products concept to market.

“I am very excited to be working with Greyson’s innovative team,” said Jeanine Recckio. “The company’s technology marks a breakthrough in the cosmetics industry that leading beauty brands need, retailers want, and consumers demand.”

Greyson International’s revolutionary patented Trilexon® delivery system allows the finest ingredients to be released topically over an extended period of time, while maintaining the skin’s natural intracellular barrier to promote natural moisture and lipid levels, providing a comfortable and durable experience that’s unlike anything else in the market.

Based on this technology, the company’s breakthrough Trilexon® foundation reduces blemishes, wrinkles and fine lines, providing a more uniform surface for color products, like make-ups, blushes and eye shadows, that remains in place even after contact with water and feels like wearing nothing a

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system that’s taking the multi-billion dollar cosmetics and OTC pharmaceuticals industries by storm. Based on this technology, the company’s patented Trilexon® foundation creates a fine surface that is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time, ensuring that the skin receives treatment at a constant steady pace to give it a healthy and youthful look. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. The company also holds an investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered, Oil and Gas Company. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

Coconut Creek, Fla. – August 30, 2012– Greyson International, Inc. (GYSN.PK) announced today that it has received its issue date and Patent number from the U.S. Patent and Trademark Office.  The Patent will be issued on September 18, 2012 and the Patent Number is 8,268,335.

The Trilexon® Delivery System Technology, allows active ingredients to work for a longer period of time than other products currently available on the market, and therefore produces results never before possible. The Trilexon® delivery system can improve the effectiveness of virtually every topical application in almost any field imaginable.

Greyson International CEO, Harvey Tauman, said “We are very confident that this patent will support us in moving forward with marketing and licensing agreements wherever active ingredients are needed. This trans-dermal delivery system could be used more effectively in cosmetic, medical and veterinary use.”

The patent is classified as a “Utility” patent and, according to the US Patent Office; a utility patent is only obtained when the invention is for a “new and useful process, machine, manufacture, or composition of matter.”

About Greyson International, Inc.

Greyson International, Inc. is a research, development and marketing company that markets health and beauty aid products. Trilexon® is a registered trademark of Greyson International. For more information, visit www.greysonintl.com; join the Greyson Facebook group page by visiting www.facebook.com.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

 

† Trilexon® is a registered trademark of Greyson International, Inc.

 

Coconut Creek, Fla. – August 24, 2012 – Greyson International, Inc. (GYSN.PK) announced today additional information in regards to its investment in Blake Oil and Gas Limited (“Blake”) a privately owned, Guernsey registered, oil and gas company.

Earlier this year Greyson acquired a private entity that owned 630,690 shares of Blake in exchange for restricted shares of Greyson’s common stock.  Each member of that entity was issued Greyson’s shares based upon their percentage of ownership in that entity.

Greyson International is not an operator of that business.  Its interest is solely as an investor. Although its shares of ownership haven’t changed, its percentage can vary depending upon the outstanding shares of Blake. Its ownership is currently at 3%.

Blake has recently entered into a Joint Venture arrangement to further exploit its Oil and Gas Assets in Georgia. Under terms of the agreement, its partner has committed over $100,000,000 in funding to further develop its oil and gas activities in the Country of Georgia. According to independent studies, these properties have been reported to have significant oil and gas reserves.  For more information please visit their website, www.blakeoilandgas.com.

About Greyson International, Inc.

Greyson International, Inc. is a research, development and marketing company that markets health and beauty aid products. Trilexon® is a registered trademark of Greyson International. For more information, visit www.greysonintl.com; join the Greyson Facebook group page by visiting www.facebook.com.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

Coconut Creek, Fla. – February 19, 2013 – Greyson International, Inc. (OTC Pink: GYSN), developer of an innovative patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced that it will be holding an investor conference call on, February 20, 2013, at 4:15 pm EDT. The conference call dial in number is 530-881-1300 and the Participant Access Code is 934487. Investors that can’t make the conference or would like to listen to it again can dial 530-881-1399 to hear a playback.

“Our company has made tremendous progress over the last several months with the launch of Trilexon® and the hiring of top industry consultants,” said Harvey Tauman, CEO of Greyson International Inc. “I’m looking forward to outlining these accomplishments as well as discussing our future plans on this call, as we bring our breakthrough products to market and ultimately unlock significant value for our shareholders in 2013 and beyond.”

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system that’s taking the multi-billion dollar cosmetics and OTC pharmaceuticals industries by storm. Based on this technology, the company’s patented Trilexon® foundation creates a fine surface that is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time, ensuring that the skin receives treatment at a constant steady pace to give it a healthy and youthful look. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. The company also holds an investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered, Oil and Gas Company. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

Coconut Creek, Fla. – November 7, 2012– Greyson International, Inc. (GYSN.PK) is entering into the $58.3 billion* cosmetic market with the creation of its new tinted Trilexon® foundation, designed to reduce fine lines that form around the eyes and mouth before applying make-ups, blushes and eye shadows. By providing an even tone, the Trilexon® foundation reduces blemishes, wrinkles, and fine lines providing a more uniform facial surface for color products. Trilexon® is the basis for many products utilizing the company’s patented delivery system, both in its existing product offerings and upcoming development pipeline.

“Trilexon® represents a breakthrough in the color cosmetic market that has eluded many of the world’s largest cosmetic companies for years,” said Harvey Tauman, CEO of Greyson International, Inc. “By creating a fine surface that’s insoluble in water, the foundation keeps in place with longer wear times despite sweat or water contact, while continuously releasing ingredients over an extended period of time to give skin a healthy and youthful look.”

Greyson’s Trilexon® technology uses a buffering system based on lactates. The pH is buffered to a range of 4.5-5.0, thus helping to maintain the skins natural pH. Maintaining the natural pH allows the natural intracellular cement of the skin cells to maintain their barrier function thereby promoting healthy skin by sustaining the natural moisture and lipid levels. Many naturally occurring enzymes that contribute to skin health and support healing, like betaglucocerebrosidase, are only active in the pH range of 4.5-5.0. The use of complexes like Dermaxyl and Metrixyl also help to plump the skin and reduce lines and wrinkles, resulting in skin smoothing. And finally, a cationic emulsifier with a prepolymer develops a water resistant film that helps promote moisture retention in the skin and minimize oil and sebum build-up over time.

“We are very excited to leverage our patented delivery system and bring our first color product to market in such a short timeframe,” added Mr. Tauman. “Trilexon® represents a breakthrough in the foundation and skin treatment space and we plan on launching several additional products next year in order to ramp up revenues and generate value for our shareholders.”

* Statistic from the Demeter Group.

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system that targets the multi-billion dollar cosmetics industry. It also holds an investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered, Oil and Gas Company. The Trilexon® system creates a fine surface that is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time, ensuring that the skin receives treatment at a constant steady pace to give it a healthy and youthful look. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. For more information, visit our website; www.greysonintl.com and join the Greyson International’s Facebook page.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

Coconut Creek, Fla. – October 15, 2012– Greyson International, Inc. (GYSN.PK) has received notification from the Depository Trust & Clearing Corporation (“DTCC”) that its shares now have full service eligibility.

Greyson International CEO Harvey Tauman says “Now that our patent has been officially issued, our company can continue the process of shifting from a research and development company into a revenue-generating company. In accordance with our master plan of becoming a full reporting company we are pleased to announce that our securities now have the benefit of DTCC’s depository services. We are requesting that our shareholders notify their brokers of this important development and request that their shares be deposited with DTCC”.

About Greyson International, Inc.

Greyson’s main asset is its recently patented Trilexon® delivery system. It also holds an investment in Blake Oil and Gas Limited (“Blake”) a privately owned, Guernsey registered, Oil and Gas Company.  The Trilexon® delivery system precisely delivers key ingredients to the appropriate areas through “messengers” in order to achieve higher effectiveness and more noticeable results. The Trilexon® system creates a fine surface which is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time; ensuring that the skin receives treatment at a constant steady pace to give the skin a healthy and youthful look. We believe that Trilexon® will have benefits in the medical field and wherever it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. For more information, visit our website; www.greysonintl.com and join the Greyson International’s Facebook page by visiting www.facebook.com.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

† Trilexon® is a registered trademark of Greyson International, Inc.

Coconut Creek, Fla. – September 19, 2012 – Greyson International, Inc. (GYSN.PK) filed today with the Depository Trust Company (“DTC”) to have its shares become “DTC-Eligible”.  This process, once effective, allows Greyson’s securities to have the benefit of DTC’s depository services.

Greyson will be holding an investor conference call on Thursday September 20, 2012, at 4:15 pm EDT.  The conference call dial in number is 530-881-1300. The Participant Access Code is 934487. The playback number is 530-881-1399.

About Greyson International, Inc.

Greyson International, Inc. is a research, development and marketing company that markets health and beauty aid products. Greyson has developed a new delivery method, the Trilexon® system, which will improve the effectiveness of active ingredients in most topical applications in today’s cosmetic and over-the-counter drug applications. Trilexon® is a registered trademark of Greyson International. For more information, visit our website; www.greysonintl.com and join the Greyson International’s Facebook page by visiting www.facebook.com.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

† Trilexon® is a registered trademark of Greyson International, Inc.

COCONUT CREEK, Fla. – January 22, 2013- Greyson International Inc. (Pink Sheets: GYSN), developer of an innovative patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced that it engaged beauty and lifestyle futurologist Jeanine Recckio and the Mirror Mirror Imagination Group to bring its patented breakthrough Trilexon® technology and cosmetic products to the next level.

“We are very excited to have engaged Jeanine Recckio to help us effectively introduce both our existing and future product lines into the retail market,” said Harvey Tauman, CEO of Greyson International Inc. “With our patented revolutionary topical Trilexon® delivery technology and several cosmetic products already in place, we are excited to bring our breakthrough products to market and ultimately unlock significant shareholder value over the coming quarters.”

Formerly a top executive at global cosmetic giants like Revlon, Estee Lauder, Coty, L’Oreal, Helena Rubinstein and Ralph Lauren Fragrances, Ms. Recckio’s trend forecasting agency Mirror Mirror Imagination Group© focuses on identifying trends that drive new business, and lending its expertise in developing, packaging, positioning and selling Fortune 500 products into retail channels like Colgate-Palmolive, P&G, Sephora, QVC, Nivea, LaPrairie, Garnier and more to launch innovative products concept to market.

“I am very excited to be working with Greyson’s innovative team,” said Jeanine Recckio. “The company’s technology marks a breakthrough in the cosmetics industry that leading beauty brands need, retailers want, and consumers demand.”

Greyson International’s revolutionary patented Trilexon® delivery system allows the finest ingredients to be released topically over an extended period of time, while maintaining the skin’s natural intracellular barrier to promote natural moisture and lipid levels, providing a comfortable and durable experience that’s unlike anything else in the market.

Based on this technology, the company’s breakthrough Trilexon® foundation reduces blemishes, wrinkles and fine lines, providing a more uniform surface for color products, like make-ups, blushes and eye shadows, that remains in place even after contact with water and feels like wearing nothing a

 About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system that’s taking the multi-billion dollar cosmetics and OTC pharmaceuticals industries by storm. Based on this technology, the company’s patented Trilexon® foundation creates a fine surface that is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time, ensuring that the skin receives treatment at a constant steady pace to give it a healthy and youthful look. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. The company also holds an investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered, Oil and Gas Company. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com